Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A27565 | 18056890 | Diabetes Care | Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. | 2007 | Details |
A27572 | 18031368 | J Gastroenterol Hepatol | Significant correlations between severe fatty liver and risk factors for metabolic syndrome. | 2007 | Details |
A27573 | 18030620 | Dig Dis Sci | Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. | 2007 | Details |
A27579 | 18007554 | Ann Hepatol | Dipeptidyl peptidase IV (DDP IV) in NASH patients. | 2008 | Details |
A27580 | 18007551 | Ann Hepatol | Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. | 2008 | Details |
A27594 | 17958019 | Rev Med Brux | [How to interpret a hyperferritinemia?]. | 2007 | Details |
A27601 | 17934820 | Dig Dis Sci | Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. | 2007 | Details |
A27607 | 17916170 | Intern Med J | The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations. | 2007 | Details |
A27645 | 17767466 | Aliment Pharmacol Ther | Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. | 2007 | Details |
A27647 | 17766001 | Diabetes Res Clin Pract | Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. | 2007 | Details |
A27669 | 17708287 | Hepatogastroenterology | Factors affecting the serum levels of adipokines in Korean male patients with nonalcoholic fatty liver disease. | 2007 | Details |
A27675 | 17694770 | Niger J Med | Diabetes co-existing with chronic liver disease: clinical features and response to therapy. | 2007 | Details |
A27679 | 17684197 | Am J Clin Nutr | Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. | 2007 | Details |
A27684 | 17671740 | Int J Mol Med | Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. | 2007 | Details |
A27694 | 17654743 | Hepatology | A lipidomic analysis of nonalcoholic fatty liver disease. | 2007 | Details |
A27697 | 17653654 | J Gastroenterol | High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. | 2007 | Details |
A27705 | 17608855 | J Gastroenterol Hepatol | Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. | 2007 | Details |
A27713 | 17589946 | World J Gastroenterol | Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. | 2007 | Details |
A27714 | 17585191 | Korean J Hepatol | [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease]. | 2007 | Details |
A27752 | 17519831 | Ann Hepatol | What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis? | 2007 | Details |
A27760 | 17498244 | Liver Int | Impact of non-alcoholic fatty liver disease on chronic hepatitis B. | 2007 | Details |
A27768 | 17486049 | Mod Pathol | Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. | 2007 | Details |
A27773 | 17476865 | Obes Surg | Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass. | 2007 | Details |
A27782 | 17464461 | J Gastroenterol | Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. | 2007 | Details |
A27783 | 17461452 | World J Gastroenterol | Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. | 2007 | Details |
A27792 | 17420951 | Dig Dis Sci | The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. | 2007 | Details |
A27797 | 17405346 | Eur Rev Med Pharmacol Sci | Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase. | 2007 | Details |
A27805 | 17395331 | J Hepatol | Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. | 2007 | Details |
A27818 | 17370058 | Diabetologia | Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men. | 2007 | Details |
A27825 | 17352011 | World J Gastroenterol | Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. | 2007 | Details |
A27828 | 17331172 | Alcohol Clin Exp Res | Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. | 2007 | Details |
A27844 | 17277038 | Diabetes Care | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. | 2007 | Details |
A27861 | 17227317 | Diabet Med | Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. | 2007 | Details |
A27863 | 17220609 | Intern Med | 1. Fatty liver and non-alcoholic steatohepatitis. | 2007 | Details |
A27874 | 17181567 | Eur J Clin Invest | Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis. | 2007 | Details |
A27877 | 17164554 | Intervirology | Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC. | 2006 | Details |
A27878 | 17164082 | Nutr Metab Cardiovasc Dis | Diabetes and liver disease: an ominous association. | 2007 | Details |
A27890 | 17096854 | BMC Gastroenterol | Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. | 2006 | Details |
A27892 | 17074020 | J Gastroenterol Hepatol | Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. | 2006 | Details |
A27898 | 17063114 | J Clin Gastroenterol | Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). | 2007 | Details |
A27899 | 17062890 | Eur J Endocrinol | Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. | 2006 | Details |
A27904 | 17053032 | J Physiol | High-fat diet-induced hepatic steatosis reduces glucagon receptor content in rat hepatocytes: potential interaction with acute exercise. | 2006 | Details |
A27924 | 17006934 | Hepatology | Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. | 2006 | Details |
A27928 | 16989692 | Obes Surg | Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. | 2006 | Details |
A27929 | 16970951 | Atherosclerosis | Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. | 2006 | Details |
A27938 | 16942668 | Curr Treat Options Gastroenterol | Nonalcoholic Fatty Liver Disease (NAFLD): Approach in the Adolescent Patient. | 2006 | Details |
A27944 | 16936910 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Non-alcoholic fatty liver disease (NAFLD)--a novel common aspect of the metabolic syndrome. | 2006 | Details |
A27954 | 16910257 | Rev Med Liege | [Management of hyperferritinemia]. | 2006 | Details |
A27979 | 16807517 | Ann Hepatol | Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF). | 2006 | Details |
A27990 | 16778754 | Minerva Cardioangiol | Nonalcoholic fatty liver disease and the metabolic syndrome. | 2006 | Details |
A28012 | 16732016 | Diabetes Care | Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. | 2006 | Details |
A28032 | 16673555 | Acta Gastroenterol Belg | Serum vitamin-E levels and its relation to clinical features in nonalcoholic fatty liver disease with elevated ALT levels. | 2006 | Details |
A28056 | 16553034 | J Endocrinol Invest | Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. | 2006 | Details |
A28117 | 16378177 | J Gastroenterol | Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? | 2005 | Details |
A28129 | 16340230 | Med Princ Pract | Demographic and clinicopathological characteristics of nonalcoholic fatty liver disease in the East-Southeastern Anatolia regions in Turkey. | 2006 | Details |
A28133 | 16306373 | Diabetes | Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. | 2005 | Details |
A28149 | 16259893 | Obes Surg | The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery. | 2005 | Details |
A28165 | 16231594 | Eur Rev Med Pharmacol Sci | The treatment of NAFLD. | 2006 | Details |
A28180 | 16225469 | Aliment Pharmacol Ther | Review article: the metabolic syndrome and non-alcoholic fatty liver disease. | 2005 | Details |
A28182 | 16214395 | Hepatol Res | Pathology of nonalcoholic steatohepatitis. | 2005 | Details |
A28187 | 16203174 | Hepatol Res | The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease. | 2005 | Details |
A28193 | 16198620 | Hepatol Res | Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). | 2005 | Details |
A28197 | 16177552 | Korean J Hepatol | [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease]. | 2005 | Details |
A28198 | 16176470 | Intern Med J | Clinical features associated with improvement of fatty liver disease. | 2005 | Details |
A28205 | 16146549 | Clin Transplant | Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? | 2005 | Details |
A28213 | 16116632 | Hepatology | A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. | 2005 | Details |
A28222 | 16088092 | Ann Nutr Metab | Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. | 2005 | Details |
A28227 | 16037946 | Hepatology | Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. | 2005 | Details |
A28235 | 15998429 | Liver Int | Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. | 2005 | Details |
A28236 | 15998427 | Liver Int | Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. | 2005 | Details |
A28237 | 15991291 | World J Gastroenterol | Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan. | 2005 | Details |
A28244 | 15980673 | Korean J Hepatol | [Clinical characteristics of factory workers with asymptomatic liver function test abnormalities found on serial health examination]. | 2005 | Details |
A28248 | 15966506 | J Endocrinol Invest | Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. | 2005 | Details |
A28252 | 15948897 | Eur J Clin Invest | Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. | 2005 | Details |
A28261 | 15920328 | Dig Dis | Should nonalcoholic fatty liver disease be renamed? | 2005 | Details |
A28285 | 15797948 | J Clin Endocrinol Metab | Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. | 2005 | Details |
A28299 | 15747110 | Diabetologia | Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. | 2005 | Details |
A28303 | 15743753 | Am J Clin Pathol | The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens. | 2005 | Details |
A28304 | 15739708 | Hosp Med | Non-alcoholic fatty liver disease. | 2005 | Details |
A28315 | 15706422 | Oncol Rep | CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients. | 2005 | Details |
A28317 | 15701296 | Curr Gastroenterol Rep | Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. | 2005 | Details |
A28333 | 15623825 | J Nutr | Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats. | 2005 | Details |
A28349 | 15544735 | Gastroenterol Hepatol | [Study of patients referred for elevated ferritin levels and/or transferrin saturation: significance of non-alcoholic fatty liver disease]. | 2004 | Details |
A28372 | 15368453 | Hepatology | Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. | 2004 | Details |
A28389 | 15278103 | Int J Obes Relat Metab Disord | Hepatic steatosis in obese Chinese children. | 2004 | Details |
A28424 | 15053039 | Korean J Intern Med | Factors associated or related to with pathological severity of nonalcoholic fatty liver disease. | 2004 | Details |
A28437 | 14762843 | Liver Transpl | Obesity and diabetes as a risk factor for hepatocellular carcinoma. | 2004 | Details |
A28439 | 14752836 | Hepatology | Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. | 2004 | Details |
A28451 | 14631324 | Diabetes Metab | Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. | 2003 | Details |
A28452 | 14620622 | Dig Liver Dis | Impaired insulin-mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of insulin resistance. | 2003 | Details |
A28478 | 12749246 | Hepatogastroenterology | Insulin resistance in patients with steatohepatitis. | 2003 | Details |
A28487 | 12668987 | Hepatology | Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. | 2003 | Details |
A28526 | 12122357 | Gastroenterol Clin Biol | [Non alcoholic steatohepatitis: a multifactorial, frequent, paucysymptomatic liver disease with a fibrotic outcome]. | 2002 | Details |
A28536 | 11910345 | Gastroenterology | Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. | 2002 | Details |
A28553 | 11473047 | Diabetes | Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. | 2001 | Details |
A28557 | 11432515 | Dig Liver Dis | Insulin resistance in non-alcoholic steatohepatitis. | 2001 | Details |
A28559 | 11422610 | J Gastroenterol Hepatol | Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. | 2001 | Details |
A28565 | 10902968 | Liver | The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. | 2000 | Details |
A28568 | 10599403 | Acta Gastroenterol Latinoam | [Steatohepatic cirrhosis in a morbidly obese patient]. | 1999 | Details |
A28575 | 9885647 | Harefuah | [Abnormal liver function tests in the primary care setting]. | 1998 | Details |